Select Medical Holdings Corporation (NYSE:SEM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $17.80.
Several equities research analysts have recently weighed in on SEM shares. Royal Bank Of Canada increased their target price on shares of Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, October 8th. Benchmark reissued a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Wall Street Zen upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Mizuho set a $17.00 price objective on shares of Select Medical in a research report on Monday, November 3rd.
Check Out Our Latest Analysis on Select Medical
Institutional Investors Weigh In On Select Medical
Select Medical Price Performance
SEM stock opened at $15.37 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. The company has a market capitalization of $1.90 billion, a P/E ratio of 17.87, a PEG ratio of 0.54 and a beta of 1.26. The business has a 50 day simple moving average of $14.72 and a 200-day simple moving average of $13.86. Select Medical has a twelve month low of $11.65 and a twelve month high of $20.83.
Select Medical (NYSE:SEM – Get Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, equities analysts anticipate that Select Medical will post 1.17 EPS for the current year.
Select Medical Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Stockholders of record on Wednesday, November 12th were issued a $0.0625 dividend. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.25 annualized dividend and a dividend yield of 1.6%. Select Medical’s payout ratio is presently 29.07%.
Select Medical Company Profile
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
See Also
- Five stocks we like better than Select Medical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
